As proof of principle that local cytokine concentration regulates anti-tumor immunity, a recent study showed that the use of the CD3 x CD123 antibody flotetuzumab or CAR123-directed T cells led to the localized release of IFN-γ from T cells and, subsequently, MHC class II upregulation on AML (47). This evidence concerns the gene IFNG and neoplasm.